VIRT (VIRT)
Quantitative Summary
DeterministicStrong operational fundamentals (Piotroski 7/9). Beneish M-Score of -1.96 exceeds the -2.22 academic threshold — earnings quality may warrant further review.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe company exhibits robust fundamental quality characterized by a high Piotroski F-Score of 7/9 and a negative Beneish M-Score of -1.96, signaling strong financial health with low earnings manipulation risk. The DuPont decomposition reveals that the 23.7% ROE is driven primarily by significant leverage (Equity Multiplier of 10.21x) rather than operational efficiency or pricing power; while net margins at 12.9% and gross margins at 64.3% indicate healthy profitability, they are insufficient to generate the return without substantial debt utilization. Asset turnover remains low at 0.18x, suggesting a capital-intensive model where returns rely heavily on financial engineering rather than rapid asset cycling.
Valuation analysis requires weighing these structural drivers against current market pricing. The stock commands a premium multiple relative to historical norms and sector peers if the high ROE is sustainable given its leverage-dependent nature. A DCF framework would likely hinge on whether future growth can decouple from this extreme equity multiplier, as implied by the 26.2% revenue growth YoY; however, maintaining such returns without increasing leverage further or improving asset efficiency presents a mathematical constraint. The market appears to be pricing in continued high-growth execution while simultaneously acknowledging the fragility inherent in an ROE structure dominated by debt.
Insider activity introduces a notable divergence from the positive fundamental metrics, with $13.5 million in net selling over the last 90 days. This capital outflow suggests internal stakeholders may perceive limited upside or are hedging against potential valuation compression despite the company's strong F-Score and revenue trajectory. The interplay between high insider liquidity events and a leverage-heavy return profile creates an asymmetric risk-reward dynamic where downside protection relies on margin stability, while upside is capped by the difficulty of sustaining 23.7% ROE without further balance sheet expansion or operational turnaround.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Insider Activity (Last 90 Days)
Open-market buys vs sells by company insiders. Source: yfinance.
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like SLYG or SPSM, the fund manager is mechanically forced to buy or sell VIRT shares regardless of VIRT's individual fundamentals. We estimate $136M of passive capital is structurally linked to VIRT through 8 tracked ETFs. Passive flows have a limited but growing influence on VIRT's daily trading dynamics.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in VIRT to visualize passive redemption contagion across ETFs and collateral stocks.
If VIRT (VIRT) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies JPMorgan Chase & Co. (JPM) as the most exposed collateral stock, sharing 1 ETFs with VIRT. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 8 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
VIRT Ownership Dynamics
ETFs with Highest VIRT Exposure
Float lock-up computed from 8 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
VIRT Capital Efficiency
How efficiently does VIRT convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
VIRT converts 23% of its EBITDA into free cash flow, a moderate conversion rate — significant EBITDA is consumed by capital expenditures, working capital changes, or interest payments. The 77% reinvestment rate signals aggressive capacity expansion.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-13 | 18,278 | $51.85 | $947,714.3 |
| 2026-05-05 | 4 | $49.55 | $198.2 |
| 2026-05-04 | 24 | $48.12 | $1,154.88 |
| 2026-04-20 | 200 | $50.65 | $10,130 |
| 2026-04-15 | 232 | $51.28 | $11,896.96 |
| 2026-04-07 | 68 | $47.49 | $3,229.32 |
| 2026-04-06 | 27 | $46.22 | $1,247.94 |
| 2026-03-31 | 1,737 | $42.84 | $74,413.08 |
| 2026-03-23 | 302 | $41.63 | $12,572.26 |
| 2026-03-10 | 95 | $41.94 | $3,984.3 |
| 2026-03-09 | 5 | $41.01 | $205.05 |
| 2026-03-04 | 563 | $41.64 | $23,443.32 |
| 2026-03-03 | 20 | $42.73 | $854.6 |
| 2026-02-27 | 100 | $41.74 | $4,174 |
| 2026-02-23 | 1,800 | $39.82 | $71,676 |
| 2026-02-20 | 1,200 | $39.37 | $47,244 |
| 2026-02-17 | 390 | $38.34 | $14,952.6 |
| 2026-02-10 | 5 | $39.26 | $196.3 |
| 2025-12-30 | 315 | $34.30 | $10,804.5 |
| 2025-12-29 | 315 | $34.12 | $10,747.8 |
| 2025-12-26 | 1,401 | $33.78 | $47,325.78 |
| 2025-12-24 | 315 | $33.38 | $10,514.7 |
| 2025-12-22 | 7,023 | $33.84 | $237,658.32 |
| 2025-12-17 | 341 | $33.85 | $11,542.85 |
| 2025-12-12 | 13,822 | $34.23 | $473,127.06 |
| 2025-12-02 | 35 | $35.02 | $1,225.7 |
| 2025-11-07 | 26 | $35.07 | $911.82 |
| 2025-10-30 | 72 | $34.39 | $2,476.08 |
| 2025-10-23 | 8,085 | $33.41 | $270,119.85 |
| 2025-10-16 | 1,400 | $33.60 | $47,040 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare VIRT to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.